Regulation of neurokinin-1 receptor expression by GABAB receptor agonists
References (19)
- et al.
Brain Res.
(1996) - et al.
Neurosci.
(1995) - et al.
Neurosci. Lett.
(1991) - et al.
Neurosci. Lett.
(1992) - et al.
Neuropharmacol.
(1985) - et al.
J. Pharmacol. and Exp. Therap.
(1991) - et al.
J. Comp. Neurol.
(1979) - et al.
- et al.
J. Pharmacol. and Exp. Therap.
(1995)
Cited by (38)
Effects of GABA <inf>B</inf> receptor agonists and antagonists on glycemia regulation in mice
2012, European Journal of PharmacologyCitation Excerpt :In view of these results, we studied the effects of prolonged treatments with these compounds on glucose homeostasis, since the inconsistencies surrounding chronic treatments with GABAB receptor agonists or antagonists have remained largely unresolved. Chronic administration of baclofen has been shown to decrease the number of GABAB receptors associated to the pharmacological effects of this agent (Enna et al., 1998; Malcangio et al., 1993) and also to induce the desensitization of the receptor without altering the mRNA expression of the GABAB subunits (Sands et al., 2003), while others reported lack of effects in different brain areas (Motohashi, 1992). Pratt et al. suggested an increase in the number of GABAB receptors in prefrontal cortex lamina I after repeated oral administration of 10 mg/kg baclofen, although not achieving statistical significance (Pratt and Bowery, 1993).
Chemistry and pharmacology of GABA <inf>B</inf> receptor ligands
2010, Advances in PharmacologyNarcolepsy and depression and the neurobiology of gammahydroxybutyrate
2009, Progress in NeurobiologyCGP 44532
2007, xPharm: The Comprehensive Pharmacology ReferenceBaclofen
2007, xPharm: The Comprehensive Pharmacology ReferenceDevelopment of baclofen tolerance in a rat model of chronic spasticity and rigidity
2006, Neuroscience Letters